Skip to main content
. 2023 Apr 22;3:101745. doi: 10.1016/j.bas.2023.101745

Table 2.

Genetic variants identified in the study cohort.

Gene Variant Frequency (gnomAD, popmax) Identification method CADD score Patients
NR4A3 NM_006981: c.C872T; p.Thr291Met 0.00006 Family-based analysis 24.8 4, 5, 6
NR4A3 NM_006981: c.C1578G; p.Ser526Arg 0.00014 Candidate gene approach (Re-analysis of genes identified in approaches 1–3) 16.01 2
PDZRN3 NM_001303139: c.C1362G; p.Ser454Arg Not previously observed Family-based analysis 25.6 4, 5, 6
TNFAIP2 NM_006291: c.C1240G; p.Gln414Glu Not previously observed Family-based analysis 12.09 4, 5, 6
AGXT2 NM_001306173: c.C703T; p.Pro235Ser Not previously observed De novo analysis 13.9 9
NOS3 NM_001160109: c.G1684A; p.Glu562Lys 0.00003 Candidate gene approach (angiogenesis gene) 33 1
ITGAV NM_001145000: c.A1313T; p.Asn438Ile Not previously observed Candidate gene approach (angiogenesis gene) 26.8 1
FGR3 NM_000142: c.A1136G; p.Tyr379Cys Not previously observed Candidate gene approach (angiogenesis gene) 25.3 2
GBR7 NM_001030002: c.G869A; p.Arg290His 0.00089 Autozygous region 32 1